ToolGen Inc
199800.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$675.76B
Close$
$-9860.81
113.3% downside
Current Fair Value
113.3% downsideOvervalued by 113.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $675.76 Billion |
|---|---|
| Enterprise Value | $667.30 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4176.31 |
| Beta | 0.26 |
| Outstanding Shares | 9,144,299 |
Return
| Return on Equity | -84.13% |
|---|---|
| Return on Assets | -76.24% |
| Return on Invested Capital | -80.49% |
Valuation & Multiples
| P/E Ratio | -7.65 |
|---|---|
| PEG | -14.06 |
| Price to Sales | 353.59 |
| Price to Book Ratio | 14.53 |
| Enterprise Value to Revenue | 348.9 |
| Enterprise Value to EBIT | -17.25 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About ToolGen Incorporated
84 employees
CEO: Young Kim ToolGen Incorporated is a biotechnology enterprise based in South Korea, primarily focused on pioneering advancements in genome editing technology. The company's main endeavor involves engineering CRISPR-Cas9 genetic modification tools s...